C WorldWide Group’s Puma Biotechnology PBYI Stock Holding History

C WorldWide Group’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-39,179	Closed	-$1.52M	–	103
2019 Q1	$1.52M	Hold	39,179	–	–	0.02%	102
2018 Q4	$797K	Sell	39,179 -15,869	-29%	-$476K	0.01%	106
2018 Q3	$2.52M	Sell	55,048 -9,537	-15%	-$460K	0.03%	89
2018 Q2	$3.82M	Buy	64,585 +40,703	+170%	+$2.36M	0.05%	76
2018 Q1	$1.63M	Buy	23,882 +2,026	+9%	+$152K	0.02%	88
2017 Q4	$2.16M	Sell	21,856 -1,936	-8%	-$217K	0.03%	82
2017 Q3	$2.85M	Sell	23,792 -16,042	-40%	-$1.49M	0.04%	80
2017 Q2	$3.48M	Buy	39,834 +6,465	+19%	+$362K	0.05%	74
2017 Q1	$1.24M	Buy	33,369 +3,369	+11%	+$123K	0.02%	101
2016 Q4	$921K	Hold	30,000	–	–	0.02%	101
2016 Q3	$2.01M	Buy	+30,000	New	+$1.52M	0.04%	89

Other funds holding PBYI

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

C WorldWide Group's PBYI Position: Q2 2019 in Review

C WorldWide Group sold out of Puma Biotechnology (PBYI) in Q2 2019, closing a stake of 39,179 shares — an estimated $1.52M sold.

C WorldWide Group first reported a position in PBYI in Q3 2016 and held it in 11 quarters. The position peaked at $3.82M in Q2 2018. 139 funds tracked by Wall St. Rank hold PBYI as of Q2 2019.

C WorldWide Group reported no remaining Puma Biotechnology position as of Q2 2019 after selling out during the quarter.
C WorldWide Group sold 39,179 Puma Biotechnology shares in Q2 2019, an estimated $1.52M.
C WorldWide Group first reported a position in Puma Biotechnology in Q3 2016 and held it in 11 quarters.
C WorldWide Group's Puma Biotechnology position peaked at $3.82M in Q2 2018.
139 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.